Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and GI oncology diseases, ...
In the late 1960s, three Weizmann Institute of Science researchers developed several protein-like molecules, called copolymers, that they believed would produce a disease similar to multiple sclerosis ...
The human heart must constantly adapt to changing demands—a task that requires tightly coordinated molecular shuffling in ...
For the first time, scientists have succeeded in artificially mimicking the ion signaling of heart muscle cells. To succeed, researchers at LiU have used organic electronics based on conductive ...
Amsterdam, NL, February, 26. 2015 - The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy (MD) can also lead to ...
No-reflow syndrome can affect people after a heart attack or a medical procedure. Dr Ashok Seth explains why clear arteries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results